Project status
In progress
Duration
Open-ended
Drug and target discovery
We deliver innovative drug and target discovery science to address to priority health and medical problems.
Our strength lies in the diversity and breadth of our experience from drug discovery and the understanding of fundamental properties of cells through to target validation and evaluating the mechanisms of disease.
We have combined inter-disciplinary expertise in drug design and chemical synthesis through to models of cell behaviour and disease.
Specific areas of research expertise include:
- Inflammation, infection and immunity including musculoskeletal and respiratory disease
- Neuroscience including depression, addiction, epilepsy, and learning and memory
- Cancer with a particular focus on prostate cancer
- Cardiovascular science pharmacology
We are committed to the training of future research leaders in drug and target discovery. Our dynamic research environment aims to generate the next generation of highly skilled researchers.
Impact case stories
Potential treatment for drug addiction relapse revealed
Research published in Addiction Biology by Drug & Target Discovery scientists at the University of Bath reveals a new potential mechanism for combatting drug addiction relapse.
Using daffodils to create cancer treatments
We're exploring how compounds derived from natural products found in daffodils could be used in potential cancer treatments.
People
Theme leader
Members
- Dr Chris Bailey
- Dr Sarah Bailey
- Dr Lorenzo Caggiano
- Dr Charlotte Dodson
- Professor Stephen Husbands
- Dr Ute Jungwirth
- Prof Banafshe Larijani
- Professor Mark Lindsay
- Dr Matthew Lloyd
- Dr Sergey Smirnov
- Dr Andrew Thompson
- Professor Stephen Ward
- Dr Tim Woodman
Visiting staff
- Professor Roland Jones
- Professor Barry Potter
- Professor Matt Thomas
- Professor Michael Threadgill
- Dr Malcolm Watson
Read about our other research themes
Find out more about research in the Department of Pharmacy & Pharmacology.